BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing
A BridgeBio Pharma drug developed for dwarfism elevated youngsters’s progress charges in a pivotal medical trial, assembly the research’s fundamental ...
A BridgeBio Pharma drug developed for dwarfism elevated youngsters’s progress charges in a pivotal medical trial, assembly the research’s fundamental ...
The Trump administration is asking Gavi, the Vaccine Alliance, to part out using vaccines containing the preservative thimerosal if it ...
Oral cholera vaccines have played a critical role in efforts to prevent and control the severe and potentially life-threatening diarrheal ...
Acute exudative pancreatitis on CT scan. Credit: Hellerhoff/Wikipedia The Experimental Drug Development Center (EDDC), Singapore's national platform for drug discovery ...
Eli Lilly already posted preliminary data showing its obesity drug, Zepbound topped Novo Nordisk’s Wegovy on measures of weight loss ...
A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first ...
Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what ...
AI-powered medical imaging company Subtle Medical was awarded Phase II funding of its NIH small business innovation research (SBIR) grant ...
Bayer’s Kerendia, already FDA approved in one cardiometabolic indication, now has data from a pivotal test that support expanding the ...
A Pfizer gene therapy for hemophilia A reduced bleeding rates in patients with the inherited blood disorder, meeting goals of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.